A new study by researcher Dr. Adeel Sarwar employed a wide dataset to unravel the complex mental health profiles accompanying attention-deficit/hyperactivity disorder (ADHD). Utilizing data from 1,528 participants, their analysis revealed startling insights into ADHD’s little-known intersection with gender identity.
Sarwar, based at Roketsan University, has long been fascinated by the psychiatric intricacies of ADHD, particularly among marginalized gender groups. Joining forces with data science expert Vitetta, founder of ADHDtest.ai, the duo embarked on an in-depth investigation of ADHD’s comorbidities through a gender-inclusive lens. Their ADHD study delved deep into nuances in condition prevalence and presentation among female, male, transgender and non-binary participants diagnosed with ADHD.
Capturing A Spectrum of Gender Identities
The cohort reflected diversity across gender identities and stages of ADHD severity:
- 756 females (49.5%)
- 378 males (24.7%)
- 36 non-binary individuals (2.4%)
- 32 transgender individuals (2.1%)
Each participant completed a comprehensive suite of validated ADHD assessments via the ADHDtest.ai platform. These diagnostics quantified ADHD severity while screening for commonly associated psychiatric conditions.
Comorbid Psychiatric Conditions in Participants with ADHD
Overall comorbidity rates among the ADHD-diagnosed participants included:
- Anxiety disorders: 40.4%
- Obsessive compulsive disorder: 12.5%
- Insomnia: 11.3%
However, striking variances emerged across gender lines…
Non-Binary Individuals:
- Anxiety disorders: 63.2%
- Autism spectrum disorders: 26.3%
- PTSD: 26.3%
Transgender Individuals:
- Anxiety disorders: 37.5%
- Autism spectrum disorders: 31.3%
- PTSD: 25%
Females:
- No additional conditions: 44.97%
- Anxiety disorders: 37.3%
- OCD: 7.94%
Conclusion:
The researchers conclude that these findings expose crucial gender distinctions in ADHD comorbidity profiles, demanding more nuanced, gender-inclusive frameworks in ADHD care.
This synopsis was written by summarizing key data and perspectives from Sarwar and Vitetta’s 2023 study published in Roketsan University’s Journal of Neuropsychiatry. For access to the complete paper, please contact the authors or visit ADHDtest.ai.
The Editorial Team at Healthcare Business Today is made up of experienced healthcare writers and editors, led by managing editor Daniel Casciato, who has over 25 years of experience in healthcare journalism. Since 1998, our team has delivered trusted, high-quality health and wellness content across numerous platforms.
Disclaimer: The content on this site is for general informational purposes only and is not intended as medical, legal, or financial advice. No content published here should be construed as a substitute for professional advice, diagnosis, or treatment. Always consult with a qualified healthcare or legal professional regarding your specific needs.
See our full disclaimer for more details.
